Unknown

Dataset Information

0

Perspectives on sipuleucel-T: Its role in the prostate cancer treatment paradigm.


ABSTRACT: Sipuleucel-T is an autologous cellular immunotherapy approved in the US for patients with asymptomatic or minimally symptomatic metastatic castration-resistant prostate cancer (mCRPC). This significant advance for mCRPC treatment provides healthcare professionals with another effective therapy to extend survival. As an immunotherapy, sipuleucel-T possesses specific characteristics differentiating it from traditional therapies. At a roundtable meeting of experts, sipuleucel-T data were discussed, focusing on interpretation and clinical implications. Important differences between immunotherapies and traditional therapies were explored, e.g., mode of action, outcomes, data consistency and robustness, timing of sipuleucel-T treatment, and future perspectives in areas such as short-term markers of long-term benefit.

SUBMITTER: Gulley JL 

PROVIDER: S-EPMC4839373 | biostudies-literature | 2016 Apr

REPOSITORIES: biostudies-literature

altmetric image

Publications

Perspectives on sipuleucel-T: Its role in the prostate cancer treatment paradigm.

Gulley James L JL   Mulders Peter P   Albers Peter P   Banchereau Jacques J   Bolla Michel M   Pantel Klaus K   Powles Thomas T  

Oncoimmunology 20151210 4


Sipuleucel-T is an autologous cellular immunotherapy approved in the US for patients with asymptomatic or minimally symptomatic metastatic castration-resistant prostate cancer (mCRPC). This significant advance for mCRPC treatment provides healthcare professionals with another effective therapy to extend survival. As an immunotherapy, sipuleucel-T possesses specific characteristics differentiating it from traditional therapies. At a roundtable meeting of experts, sipuleucel-T data were discussed,  ...[more]

Similar Datasets

| S-EPMC4456994 | biostudies-literature
| S-EPMC5925432 | biostudies-literature
| S-EPMC3712699 | biostudies-literature
| S-EPMC5131740 | biostudies-literature
| S-EPMC4523381 | biostudies-literature
| S-EPMC3662847 | biostudies-other
| S-EPMC4279604 | biostudies-literature
| S-EPMC3283534 | biostudies-other
| S-EPMC5591782 | biostudies-other
| S-EPMC8428221 | biostudies-literature